JF
KYTX icon

Jump Financial’s Kyverna Therapeutics KYTX Stock Holding History

Jump Financial’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$903K Buy
101,352
+48,590
+92% +$431K 0.01% 1235
2026
Q1 		$455K Sell
52,762
-27,537
-34% -$229K 0.01% 1298
2025
Q4 		$755K Buy
+80,299
New +$596K 0.01% 1103
2024
Q3 		– Sell
-66,960
Closed -$502K – 2194
2024
Q2 		$502K Buy
+66,960
New +$1.02M 0.01% 1129

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.32B AUM 1.62% 1-Year Est. Return

Jump Financial's KYTX Position: Q2 2026 in Review

Jump Financial increased its Kyverna Therapeutics (KYTX) stake by 92% in Q2 2026, buying an estimated $431K and bringing the position to 101,352 shares worth $903K. The position accounts for 0.01% of the portfolio, ranked #1235.

Jump Financial first reported a position in KYTX in Q2 2024 and has held it in 4 quarters since. 120 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • Jump Financial held 101,352 shares of Kyverna Therapeutics worth $903K as of Q2 2026.
  • Jump Financial bought 48,590 Kyverna Therapeutics shares in Q2 2026, an estimated $431K.
  • Kyverna Therapeutics made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1235 holding.
  • Jump Financial first reported a position in Kyverna Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • 120 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.